Arif Haad A, Morales Jose A, Brito Emmanuel, Moore Simon T, Lin Carol A
School of Medicine, University of California Riverside, Riverside, California.
Department of Orthopaedics, University of Arizona, Tucson, Arizona.
J Bone Joint Surg Am. 2025 May 22;107(14):1561-1569. doi: 10.2106/JBJS.24.01213.
Acute compartment syndrome (ACS) is a medical emergency and a cause of medical litigation across multiple specialties. We sought to compare the characteristics and outcomes of ACS-related litigation levied against surgeons in orthopaedics compared with other specialties.
The Westlaw database was queried for ACS-related cases filed within the United States between 1980 and 2023 using the search term "compartment syndrome." Inclusion criteria were defined as all jury verdicts or settlements tied to alleged medical malpractice concerning ACS of the spine and extremities. ACS cases of the abdomen were excluded.
Of 755 cases, 358 cases met inclusion criteria, 150 (42%) of which listed an orthopaedic surgeon as a defendant. A defendant verdict was reached in 203 cases (57%), a plaintiff verdict was reached in 88 cases (25%), and 67 cases (19%) were settled. The mean payout in orthopaedic cases was $3,219,519. Compared with non-orthopaedic practitioners, orthopaedic surgeons were significantly more likely to be named in cases in which ACS was due to surgery or fracture (both, p < 0.001) and in which the basis of litigation was alleged improper cast or splint application (p < 0.001). Orthopaedic surgeons were significantly less likely to be named in ACS cases when the basis of litigation was alleged negligent medication administration (p < 0.001). Only 3 cases (0.8%) mentioned documentation of compartment checks and intracompartmental pressures, and no cases were levied because of unnecessary fasciotomy. Two cases described the use of postoperative regional anesthesia for pain control.
ACS-related litigation is associated with a considerable financial burden in the wake of substantial morbidity and mortality. Lawsuits against orthopaedic surgeons more commonly involve fractures and cast or splint application, whereas those against non-orthopaedists more commonly involve medication or fluid infiltration. Documentation of close monitoring for symptoms specifically related to ACS and intracompartmental pressure measures may be a valid method to mitigate associated medicolegal risk. Prophylactic fasciotomies have not historically been a source of litigation.
Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
急性骨筋膜室综合征(ACS)是一种医疗急症,也是多个专科医疗诉讼的一个原因。我们试图比较针对骨科外科医生与其他专科医生提起的与ACS相关诉讼的特点和结果。
使用搜索词“骨筋膜室综合征”在Westlaw数据库中查询1980年至2023年在美国提起的与ACS相关的案件。纳入标准定义为所有与脊柱和四肢ACS的医疗过失指控相关的陪审团裁决或和解。腹部ACS病例被排除。
在755个案件中,358个案件符合纳入标准,其中150个(42%)将骨科外科医生列为被告。203个案件(57%)达成被告胜诉裁决,88个案件(25%)达成原告胜诉裁决,67个案件(19%)达成和解。骨科案件的平均赔付金额为3219519美元。与非骨科从业者相比,在ACS由手术或骨折导致的案件(两者p<0.001)以及诉讼依据是所称石膏或夹板应用不当的案件中(p<0.001),骨科外科医生被点名的可能性显著更高。当诉讼依据是所称疏忽用药时,骨科外科医生在ACS案件中被点名的可能性显著更低(p<0.001)。只有3个案件(0.8%)提到了骨筋膜室检查和骨筋膜室内压力的记录,没有案件因不必要的筋膜切开术而被提起诉讼。有2个案件描述了使用术后区域麻醉进行疼痛控制。
在出现严重的发病率和死亡率后,与ACS相关的诉讼会带来相当大的经济负担。针对骨科外科医生的诉讼更常见地涉及骨折以及石膏或夹板的应用,而针对非骨科医生的诉讼更常见地涉及用药或液体渗漏。对与ACS具体相关症状的密切监测记录以及骨筋膜室内压力测量可能是减轻相关医疗法律风险的有效方法。预防性筋膜切开术历来不是诉讼的根源。
治疗性三级。有关证据水平的完整描述,请参阅作者指南。